A NEW STABILITY INDICATING UPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF METOLAZONE AND SPIRONOLACTONE IN BULK AND IN ITS PHARMACEUTICAL FORMULATIONS
Objective: The objective of the work is to develop and validate a new, simple, highly sensitive RP-UPLC method for simultaneous estimation of Metolazone and Spironolactone in bulk and in its dosage forms.
Methods: The method was developed on a reversed-phase Hypersil Gold C18 (2.1Ã— 100 mm, 2.7 Âµm) column with isocratic elution. Detection was done by UV-Spectroscopy at a detection wavelength of 235 nm. The analytical procedure was validated by assessing the specificity, linearity, precision, accuracy, limit of detection, limit of quantification, robustness and ruggedness as per ICH guidelines.
Results: The results were obtained as follows- the retention times were found to be around 2.888 min and 3.835 min, the percentage purity was observed to be 99 % w/v and 100 % w/v, the percentage recovery was found to be 99.90% and 99.9% respectively for Metolazone and Spironolactone. Calibration plots were linear (r2 > 0.999) over the concentration range of 12 to 28Î¼g/ml for Metolazolone and 120 to 280Î¼g/ml for Spironolactone. The LOD was 0.0002Âµg/ml for Metolazone and 0.01Âµg/ml for Spironolactone. The LOQ was found to be 0.0008Âµg/ml for Metolazone and 0.003Âµg/ml for Spironolactone.
Conclusion: The developed analytical method for the simultaneous quantitation of Metolazone and Spironolactone was found to be specific, rapid, reliable, and reproducible. No interference from any component of pharmaceutical dosage form was observed. The method is amenable to the routine analysis of large numbers of samples with good precision and accuracy.
2. Frank Settle. Instrumental techniques for analytical chemistry, Prentice Hall. 3rd edition; 2004. p. 73-4.
3. Garry D. Christian. Analytical chemistry, 6th edition. John Wiley and Sons; 2003. p. 126-33.
4. Sharma BK. Instrumental methods of chemical analysis, Goel Publishing House, 25th edition; 2006. p. 286-8.
5. Aarti Chaudhary, KR Vadalia, Punam Thummer. Development and validation of ratio derivative spectrophotometric method for simultaneous estimation of Metolazone and Spironolactone in pharmaceutical dosage form. Int J Pharm Sci Res 2012;3:10.
6. WJ Bachaman, JT Stewart. HPLC-photolysis-electrochemical detection in pharmaceutical analysis: application to the determination of spironolactone and hydrochlorothiazide in tablets. J Chromatogr Sci 1990;28(3):123â€“8.
7. Bhojani Maulik, Dadhania Ketan, Faldu Shital. Development and validation of RP-HPLC method for simultaneous estimation of furosemide and spironolactone in their combined tablet dosage form. J Pharm Sci Biosci Res 2012;2(3):144-7.
8. Dana Muntean, Laurian Vlase, Silvia Imre, Marcela Achim, Daniela-Lucia Muntean. Determination of spironolactone and canrenone in human plasma by high-performance liquid chromatography with mass spectrometry detection. Croat Chem Acta 2011;84(3):361â€“6.
9. Devika GS, M Sudhakar, J Venkateshwara Rao, Ramesh petchi R. A simple RP-HPLC method for simultaneous estimation of torasemide and spirinolactone in tablets. J Pharm Res 2011;4(3):601-3.
10. Devika GS, M Sudhakar, J Venkateshwara Rao. RP-HPLC method for simultaneous estimation of Metolazone and Ramipril in oral solid dosage form. Int J Pharm Bio Sci 2012;3(4):193â€“200.
11. B Durga Prasad, B Chandra Kanth, R Vasanthi, M Ram Mohan, D Prabhakar. A Validated UV spectroscopic method of Metolazone in bulk and its tablet dosage forms. Int J Biol Pharm Res 2012;3(1):154-7.
12. Govind Kher, Vijay Ram, Mukesh Kher, Hitendra Joshi. Development and Validation of a HPTLC method for simultaneous determination of furosemide and spironolactone in its tablet formulation. Res J Pharm Biol Chem Sci 2013;4(1):365.